February 25, 2025 - 12:43

In an era where technology increasingly intertwines with daily life, three new books delve into the intricate and sometimes contentious relationship humans have with robots, artificial intelligence, and automation. These works tackle the emotional, ethical, and social implications of our growing reliance on machines.
One book offers a historical perspective, tracing the evolution of robotics and AI from early concepts to their current capabilities. It highlights how these advancements have transformed industries and personal interactions. Another text focuses on the psychological aspects, examining how individuals form attachments to machines and the potential consequences of these bonds.
The third book takes a critical look at the societal impact of automation, questioning the future of work and the human experience in a world increasingly dominated by technology. Collectively, these books provide a thought-provoking exploration of our relationship with machines, urging readers to consider the implications of a future where the line between human and robot continues to blur.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...